Skip to content
AwardedCzechiaGoodsCZK 29,130,855

RAMUCIRUMAB, GILTERITINIB, GLOFITAMAB 2025

Published
Published 11 March 2025
Deadline
Closed 15 May 2025

Overview

Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků splňujících požadavky SÚKL

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 29,130,855
Procedure
Open
SME suitable
Yes
Published
11 March 2025
Deadline
Closed
Classification (CPV)
Antineoplastic and immunomodulating agents

Award outcome

Awarded value
CZK 29,930,737
Award date
12 June 2025
Contract period
30 May 2025 → 14 May 2028
Winners
  • PHOENIX lékárenský velkoobchod, s.r.o.
  • ROCHE s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    30 June 2025

  2. Contract Notice

    11 April 2025

  3. Contract Notice

    21 March 2025

  4. Contract Notice

    11 March 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: RAMUCIRUMAB, GILTERITINIB, GLOFITAMAB 2025 — won by PHOENIX lékárenský velkoobchod, s.r.o. +1 — Skim